Jesse Fike, MD
Dermatology · San Antonio, TXNPI 1326545971
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $898 of the $998 with a category attached, or 90.0%. It is spread thinly across 8 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $508 and has fallen 60.4% since, to $201 in 2025. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 12 payments — averaging $83.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$235
- Johnson & Johnson$225
- Lilly USA, LLC$144
- Verrica Pharmaceuticals Inc.$113
- Kyowa Kirin, Inc.$101
- AbbVie$85
- plus $94 from 2 others
What the payments were for
- Food & beverage$89890%
- Education$10010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 2 | $235 |
| Johnson & Johnson | 2 | $225 |
| Lilly USA, LLC | 2 | $144 |
| Verrica Pharmaceuticals Inc. | 1 | $113 |
| Kyowa Kirin, Inc. | 1 | $101 |
| AbbVie | 1 | $85 |
| Sanofi | 1 | $60 |
| Krystal Biotech Inc | 2 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$998 in reported general payments places this provider in the 25th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 191 | $3,611 |
| Pimecrolimus | 11 | $2,735 |
| Clobetasol Propionate | 96 | $2,636 |
| Clindamycin Phosphate | 52 | $1,904 |
| Metronidazole | 23 | $1,272 |
| Tretinoin | 17 | $1,174 |
| Dapsone | 21 | $1,130 |
| Fluorouracil | 11 | $921 |
| Triamcinolone Acetonide | 63 | $762 |
| Fluocinonide | 17 | $557 |
| Hydrocortisone | 57 | $496 |
| Doxycycline Hyclate | 23 | $445 |
| Mupirocin | 33 | $281 |
| Minoxidil | 17 | $179 |
| Spironolactone | 14 | $155 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Antonio
- William CragunSan Antonio$2.2M
- Emily BeckerSan Antonio$1.2M
- Lindsey FinkleaSan Antonio$435K
- John BrowningSan Antonio$351K
- Vivian BucaySan Antonio$241K
- Annabelle GarciaSan Antonio$215K
- Edward LainAustin$2.5M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.